Differentiation between drug-type, fibre-type and intermediate-type in cannabis samples: HPLC-UV versus GC-FID
Journal of Pharmaceutical and Biopharmaceutical Research · 2021
DOI: 10.25082/jpbr.2020.02.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biopharmaceutical Research, 2021. Verfasst von Kian Kadkhodaei und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Cannabis sativa is known to be the most abused illegal drug worldwide. To date it is not only used as a medicine but has been established as a lifestyle product. The most relevant phytocannabinoids represent the ingredients delta-9-tetrahydrocannabinol (9-THC) and cannabidiol (CBD), whereby only 9-THC shows a psychoactive effect. Since 2017, the so-called CBD-hemp containing CBD as main ingredient is distributed in many countries as a legal alternative. In these products, 9-THC must not exceed a certain percentage. It is hardly possible to differentiate between THC-hemp and CBD-hemp presenting a major challenge for authorities. Therefore, there is the need to develop fast and efficient analysis methods to distinguish between fibre-type, drug-type and intermediate-type cannabis products. The aim of this study was to compare two simple and inexpensive HPLC-UV and GC-FID methods for their ability to quantify phytocannabinoids in dried cannabis plant material. For this purpose, a set of 37 fresh and dried cannabis samples randomly chosen from seizures of Austrian police was subject to complementary quantification of 9-THC and CBD. After having taken into account decomposition of certain phytocannabinoids, the result of this quantitative study showed good correlation between HPLC-UV and GC-FID regardless of quantifying cannabis leaves or buds.
Zitieren
APA
Kadkhodaei, K., Biei, N., Vidiella, E. C., Osmenaj, P., Cannazza, G., & Schmid, M. G. (2021). Differentiation between drug-type, fibre-type and intermediate-type in cannabis samples: HPLC-UV versus GC-FID. Journal of Pharmaceutical and Biopharmaceutical Research. https://doi.org/10.25082/jpbr.2020.02.003
Vancouver
Kadkhodaei K, Biei N, Vidiella EC, Osmenaj P, Cannazza G, Schmid MG. Differentiation between drug-type, fibre-type and intermediate-type in cannabis samples: HPLC-UV versus GC-FID. Journal of Pharmaceutical and Biopharmaceutical Research. 2021. doi:10.25082/jpbr.2020.02.003
BibTeX
@article{Kadkhodaei2021,
author = {Kadkhodaei, Kian and Biei, Nina and Vidiella, Esther Caelles and Osmenaj, Pamela and Cannazza, Giuseppe and Schmid, Martin G.},
title = {Differentiation between drug-type, fibre-type and intermediate-type in cannabis samples: HPLC-UV versus GC-FID},
journal = {Journal of Pharmaceutical and Biopharmaceutical Research},
year = {2021},
doi = {10.25082/jpbr.2020.02.003}
}
EUVIMED